Antibiotic TA is a hybrid polyketide/non-ribosomal peptide with an unusual alkylation pattern. Because alkylation has been shown in several cases to increase the activities of bioactive compounds, understanding the alkylation strategy utilized in the biosynthesis of antibiotic TA would be relevant to efforts to engineer novel alkylated therapeutic candidates. I hypothesize that the C13 ethyl and a methyl precursor to the C17 methoxymethyl in antibiotic TA are installed by a recently characterized isoprenoid-like alkylation strategy. I further hypothesize that the C17 methyl precursor undergoes a hydroxylation/O-methylation sequence to generate the final methoxymethyl structure. This hypothesis is based on several observations. First, the locations of the alkyl branches are consistent with an isoprenoid-like origin from 2-ketothioester biosynthetic intermediates. Second, the antibiotic TA biosynthetic cluster contains homologs of a cassette of proteins responsible for the methylation of a Bacillus subtilis secondary metabolite by a similar strategy. Finally, feeding studies utilizing isotopically labeled precursors are consistent with the proposed alkylation pathway.
The specific aims of the proposed research are to reconstitute the alkylation sequence on model substrates in vitro using the antibiotic TA biosynthetic proteins expressed heterologously in E. coli, and to identify the components of the pathway that discriminate between the two alkylation sites and determine branch identities. Relevance The proposed research is relevant to public health in that it will aid access to therapeutic candidates that would otherwise be too complex to synthesize chemically. By characterizing the proteins involved in the production of antibiotic TA, it may be possible to use these proteins to engineer new, more effective analogs of already existing drugs. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM081743-02
Application #
7382551
Study Section
Special Emphasis Panel (ZRG1-F04A-D (20))
Program Officer
Fabian, Miles
Project Start
2007-03-01
Project End
2008-07-25
Budget Start
2008-03-01
Budget End
2008-07-25
Support Year
2
Fiscal Year
2008
Total Cost
$20,760
Indirect Cost
Name
Harvard University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Calderone, Christopher T (2008) Isoprenoid-like alkylations in polyketide biosynthesis. Nat Prod Rep 25:845-53
Calderone, Christopher T; Bumpus, Stefanie B; Kelleher, Neil L et al. (2008) A ketoreductase domain in the PksJ protein of the bacillaene assembly line carries out both alpha- and beta-ketone reduction during chain growth. Proc Natl Acad Sci U S A 105:12809-14
Bumpus, Stefanie B; Magarvey, Nathan A; Kelleher, Neil L et al. (2008) Polyunsaturated fatty-acid-like trans-enoyl reductases utilized in polyketide biosynthesis. J Am Chem Soc 130:11614-6
Calderone, Christopher T; Iwig, David F; Dorrestein, Pieter C et al. (2007) Incorporation of nonmethyl branches by isoprenoid-like logic: multiple beta-alkylation events in the biosynthesis of myxovirescin A1. Chem Biol 14:835-46